首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Kidney360

缩写:KIDNEY360

ISSN:2641-7650

e-ISSN:2641-7650

IF/分区:3.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1879
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kazunori Satokata,Shin Goto,Hiroki Yamaguchi et al. Kazunori Satokata et al.
Background: Aberrant mucosal immune responses are underlying causes of Immunoglobulin A nephropathy (IgAN), the most prevalent type of chronic glomerulonephritis. However, the role of T cells in IgAN pathogenesis remains ...
Isabel G Scalia,Juan M Farina,Mahmoud H Abdelnabi et al. Isabel G Scalia et al.
Background: Incident atrial fibrillation (AF) is common following kidney transplantation (KTx) and is associated with worse clinical outcomes. Artificial intelligence electrocardiography (AI-ECG) algorithms have demonstra...
Farah Yasmin,Sophia C Faulkner,Abinet M Aklilu et al. Farah Yasmin et al.
Background: Rhabdomyolysis (RM) is the etiology in 7-10% of cases of AKI and benefits from early, aggressive volume repletion. RM as an etiology of AKI is often missed in clinical setting as it requires specific diagnosti...
Shingo Ishii,Tatsuki Tanaka,Yusuke Suzuki et al. Shingo Ishii et al.
Background: Decreased skeletal muscle mass is common in hemodialysis patients and contributes to adverse outcomes. However, muscle mass alone does not fully capture muscle health. An imbalance between extracellular and in...
Bhavya Bharathan,Bismark O Frimpong,Leyuan Xu et al. Bhavya Bharathan et al.
Background: Following acute kidney injury, successful regeneration of tubular epithelium is essential to restore normal kidney function. We have previously reported that arginase-1 expressing macrophages in the outer medu...
Panupong Hansrivijit,Elisabetta Patorno,Helen Tesfaye et al. Panupong Hansrivijit et al.
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) are effective in managing chronic kidney disease (CKD) and type 2 diabetes (T2D). However, there are co...